Organogenesis Holdings INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Glenn H. Nussdorf and associated trusts updated their beneficial ownership in Organogenesis Holdings Inc. to 9.7% following the dissolution of a prior shareholder group.
NASDAQ
SCHEDULE 13D/A: Organogenesis Holdings Major Shareholders Dissolve Controlling Group, Shift to Individual Reporting
A group of significant shareholders in Organogenesis Holdings Inc., including Alan A. Ades, Albert Erani, Glenn H. Nussdorf, and Dennis Erani, have formally dissolved their 'group' status under SEC Rule 13d-5, transitioning to individual beneficial ownership reporting following the termination of their Controlling Stockholders' Agreement.
NASDAQ
SCHEDULE 13D/A: Organogenesis Holdings: Key Insiders Update Significant Shareholdings in Latest SEC Filing
A group of significant shareholders, including Alan A. Ades and Albert Erani, have filed Amendment No. 9 to their Schedule 13D, detailing updated beneficial ownership percentages and recent share transfers, notably a large gift for estate planning purposes.
NASDAQ
SCHEDULE 13D/A: Key Shareholders Update Significant Holdings in Organogenesis Holdings Inc. via Schedule 13D Amendment
A group of significant shareholders, including Alan A. Ades and Albert Erani, have filed an Amendment No. 8 to their Schedule 13D, updating their beneficial ownership in Organogenesis Holdings Inc. and disclosing recent share transfers and a company repurchase.